BioCentury | Aug 20, 2012
Clinical News

CPAPP-A* test: Pivotal trial data

...patients with PAPPA levels of >=6 µIU/mL at baseline (n=644) as measured by the company's cPAPP-A* test...
...chronic angina, through its acquisition of CV Therapeutics in 2009. Danaher Corp. (NYSE:DHR), Washington Product: CPAPP-A* test...
Items per page:
1 - 1 of 1